Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, November 2012

Sort by: Newest first Oldest first A-Z Z-A

  • Decriminalisation of dispensing errors on APPG radar Subscription

    30 NOV 2012 12:25

    Decriminalisation of dispensing errors is to be the subject of a public meeting held by the All-Party Pharmacy Group in the New Year, the group announced today (30 November 2012). The APPG will invite representatives from the Crown Prosecution Service, the Medicines and Healthcare products Regulatory Agency and Department of Health to discuss the matter.

  • Lung cancer illustration (Sebastian Kaulitzki/Dreamstime.com)

    First drug for ALK-positive lung cancer to launch Subscription

    30 NOV 2012 12:18

    Crizotinib will be launched on Monday (3 December 2012) for certain patients with advanced non-small-cell lung cancer (NSCLC). The new drug, which was developed by Pfizer and is marketed as Xalkori, is for adults with previously treated anaplastic lymphoma kinase (ALK)-positive NSCLC.

  • EMA says action needed on shortages from manufacturing problems Subscription

    30 NOV 2012 12:12

    Action is needed at a European level to prevent further public health crises occurring due to drug shortages caused by manufacturing problems, the European Medicines Agency says.

  • Blood clot (Sebastian Kaulitzki/Dreamstime.com)

    Aspirin for VTE recurrence equivocal Subscription

    30 NOV 2012 11:59

    Treatment with low-dose aspirin after stopping anticoagulation does not reduce the risk of unprovoked venous thromboembolism (VTE) recurrence. However, among certain patients but it does reduce their risk of having a major vascular event (New England Journal of Medicine 2012;367:1979).

  • New look PharmOutcomes will give real-time outcomes data Subscription

    29 NOV 2012 16:39

    PharmOutcomes is being updated in April 2013 as part of a new partnership between the Pharmaceutical Services Negotiating Committee and Pinnacle Health Partnership LLP.

  • Interprofessional working must be a priority, say MPs Subscription

    29 NOV 2012 14:02

    Commissioners must make effective interprofessional working a priority, chairman of the All-Party Pharmacy Group Kevin Barron said this week (27 November 2012) following a roundtable discussion organised as part of the group’s inquiry into the topic.

  • Enhanced services down by over 5 per cent Subscription

    29 NOV 2012 14:00

    Commissioning of local enhanced pharmacy services in England decreased by more than 5 per cent in 2011–12 compared with the previous year, latest statistics show.

  • Mannitol endorsed for cystic fibrosis use Subscription

    29 NOV 2012 13:56

    Mannitol inhalation powder (Bronchitol; Pharmaxis) can be prescribed for cystic fibrosis patients who cannot use other treatments, the National Institute for Health and Clinical Excellence says.

  • Red ribbon  (Thinglass/Dreamstime.com)

    New HIV standards highlight pharmacy input Subscription

    29 NOV 2012 13:41

    A specialist HIV pharmacist must review each HIV patient as part of a multidisciplinary team of experts, says a new set of quality standards of care for people living with HIV in the UK, published by the British HIV Association this week (29 November 2012).

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.